The Immersive Experience of Virtual Reality During Chemotherapy in Patients With Early Breast and Gynecological Cancers: the Patient's Dream Study
Breast Cancer
About this trial
This is an interventional supportive care trial for Breast Cancer focused on measuring breast cancer, virtual reality, supportive care
Eligibility Criteria
Inclusion Criteria
- diagnosis of breast or ovarian cancer confirmed histologically, from I to III stage;
- surgery as first therapeutic approach (in case of ovarian cancer, patients with minimal residual disease after surgery will be also included)
- first cycle of adjuvant CT, with or without a biological treatment according to the specific cancer (regimens including anthracyclines/taxanes, anthracyclines/cyclophosphamide, carboplatinum/taxane combined or not with trastuzumab for breast cancer, carboplatin/paclitaxel combined or not with bevacizumab for ovarian cancer);
- aged ≥ 18 years;
- performance status (ECOG) 0-2;
- life expectancy > 12 months;
- ability to understand and sign the informed consent.
Exclusion Criteria:
- presenting prior history of seizures;
- disorders of the mood;
- previous history of alcohol and/or drug addiction;
- disorder of vision and eyes;
- history of psychiatric pathologies.
Sites / Locations
- alessandra Fabi
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
virtual reality
control arm
In The VRE arm, patients will use Virtual Reality headset (VR Headset), containing a selection of audiovisual productions made with 360 degrees technology and selected on the basis of content, plot and production dynamics. During the entire experience, an operator dedicated to patient care will be present to allow the most possible comfortable experience.
In control arm, patients will entertain themselves with conventional means such as listening to music, watching a mobile program, reading newspapers, books, magazines or also doing nothing, according to the patient's preferences